financetom
Business
financetom
/
Business
/
World could see 1.5°C rise in next five years: World Meteorological Organization
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
World could see 1.5°C rise in next five years: World Meteorological Organization
May 9, 2022 9:56 PM

The world faces a 50 percent chance of warming of 1.5 degrees Celsius above pre-industrial levels, if only briefly, by 2026, the World Meteorological Organization (WMO) said on Monday.

That does not mean the world would be crossing the long-term warming threshold of 1.5°C (2.7 degrees Fahrenheit), which scientists have set as the ceiling for avoiding catastrophic climate change. But a year of warming at 1.5°C could offer a taste of what crossing that long-term threshold would be like.

"We are getting measurably closer to temporarily reaching the lower target of the Paris Agreement," said WMO Secretary-General Petteri Taalas, referring to climate accords adopted in 2015.

The likelihood of exceeding 1.5°C for a short period has been rising since 2015, with scientists in 2020 estimating a 20 percent chance and revising that last year up to 40 percent. Even one year at 1.5°C of warming can have dire impacts, such as killing many of the world's coral reefs and shrinking Arctic sea ice cover. In terms of the long-term average, the average global temperature is now about 1.1°C warmer than the pre-industrial average.

"Loss and damage associated with, or exacerbated by, climate change is already occurring, some of it likely irreversible for the foreseeable future," said Maxx Dilley, deputy director of climate at the WMO.

World leaders pledged under the 2015 Paris Agreement to prevent crossing the long-term 1.5°C threshold measured as a multi-decadal average but so far have fallen short on cutting climate-warming emissions. Today's activities and current policies have the world on track to warm by about 3.2°C by the end of the century.

"It's important to remember that once we hit 1.5°C, the lack of science-based emissions policies mean that we will suffer worsening impacts as we approach 1.6°C, 1.7°C, and every increment of warming thereafter," said Kim Cobb, a climate scientist at the Georgia Institute of Technology.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ChargePoint Analyst Remains Cautious About Long-Term Profitability
ChargePoint Analyst Remains Cautious About Long-Term Profitability
Mar 5, 2025
ChargePoint Holdings, Inc. ( CHPT ) shares are trading higher on Wednesday. JPMorgan analyst Bill Peterson remained Underweight with a price forecast of 81 cents following fourth-quarter results reported yesterday. The company reported quarterly losses of 14 cents per share, in line with the analyst consensus estimate. Revenue of $101.88 million beat the analyst consensus estimate of $101.71 million. For the first fiscal quarter, ChargePoint...
Alphabet's YouTube Expands Pilot of Premium Lite Subscription to US
Alphabet's YouTube Expands Pilot of Premium Lite Subscription to US
Mar 5, 2025
12:06 PM EST, 03/05/2025 (MT Newswires) -- Alphabet's (GOOG) YouTube ( GOOG ) said Wednesday it is expanding the pilot of its Premium Lite subscription to the US. Premium Lite allows users to watch most videos on YouTube ( GOOG ) ad-free for $7.99 a month, YouTube ( GOOG ) said, adding that the subscription will also be available in...
Silexion Therapeutics' Preclinical Cancer Candidate Shows Tumor Reduction For Pancreatic Cancer
Silexion Therapeutics' Preclinical Cancer Candidate Shows Tumor Reduction For Pancreatic Cancer
Mar 5, 2025
Silexion Therapeutics Corp. released data on Wednesday from orthotopic pancreatic cancer models demonstrating that subcutaneously administered SIL204 effectively reduces primary tumor growth and metastatic spread. These findings significantly advance over previously reported data by validating SIL204’s efficacy in the more clinically relevant orthotopic setting, where human pancreatic tumor cells are implanted directly into the pancreas to better mimic human disease progression. Also...
MOVES-Goldman Sachs names Dubner as COO global M&A-memo
MOVES-Goldman Sachs names Dubner as COO global M&A-memo
Mar 5, 2025
NEW YORK, March 5 (Reuters) - Goldman Sachs ( GS ) named David Dubner as chief operating officer of global mergers and acquisitions, according to a memo seen by Reuters on Wednesday, beefing up leadership in one of its most important businesses. Goldman Sachs ( GS ) has consistently topped the M&A league tables for years, advising on some the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved